These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 15530433)
1. Determination of the transphosphorylation sites of Jak2 kinase. Matsuda T; Feng J; Witthuhn BA; Sekine Y; Ihle JN Biochem Biophys Res Commun; 2004 Dec; 325(2):586-94. PubMed ID: 15530433 [TBL] [Abstract][Full Text] [Related]
2. Regulation of JAK2 protein expression by chronic, pulsatile GH administration in vivo: a possible mechanism for ligand enhancement of signal transduction. Zhou Y; Wang X; Hadley J; Corey SJ; Vasilatos-Younken R Gen Comp Endocrinol; 2005 Nov; 144(2):128-39. PubMed ID: 15993410 [TBL] [Abstract][Full Text] [Related]
3. Expression, purification, characterization and crystallization of non- and phosphorylated states of JAK2 and JAK3 kinase domain. Hall T; Emmons TL; Chrencik JE; Gormley JA; Weinberg RA; Leone JW; Hirsch JL; Saabye MJ; Schindler JF; Day JE; Williams JM; Kiefer JR; Lightle SA; Harris MS; Guru S; Fischer HD; Tomasselli AG Protein Expr Purif; 2010 Jan; 69(1):54-63. PubMed ID: 19781647 [TBL] [Abstract][Full Text] [Related]
4. Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Feng J; Witthuhn BA; Matsuda T; Kohlhuber F; Kerr IM; Ihle JN Mol Cell Biol; 1997 May; 17(5):2497-501. PubMed ID: 9111318 [TBL] [Abstract][Full Text] [Related]
5. Identification of 1,2,3,4,5,6-hexabromocyclohexane as a small molecule inhibitor of jak2 tyrosine kinase autophosphorylation [correction of autophophorylation]. Sandberg EM; Ma X; He K; Frank SJ; Ostrov DA; Sayeski PP J Med Chem; 2005 Apr; 48(7):2526-33. PubMed ID: 15801842 [TBL] [Abstract][Full Text] [Related]
6. Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity. Argetsinger LS; Kouadio JL; Steen H; Stensballe A; Jensen ON; Carter-Su C Mol Cell Biol; 2004 Jun; 24(11):4955-67. PubMed ID: 15143187 [TBL] [Abstract][Full Text] [Related]
7. dDYRK2: a novel dual-specificity tyrosine-phosphorylation-regulated kinase in Drosophila. Lochhead PA; Sibbet G; Kinstrie R; Cleghon T; Rylatt M; Morrison DK; Cleghon V Biochem J; 2003 Sep; 374(Pt 2):381-91. PubMed ID: 12786602 [TBL] [Abstract][Full Text] [Related]
8. Activation loop phosphorylation-independent kinase activity of human protein kinase C zeta. Ranganathan S; Wang Y; Kern FG; Qu Z; Li R Proteins; 2007 May; 67(3):709-19. PubMed ID: 17335005 [TBL] [Abstract][Full Text] [Related]
9. Partial activation of the insulin receptor kinase domain by juxtamembrane autophosphorylation. Cann AD; Bishop SM; Ablooglu AJ; Kohanski RA Biochemistry; 1998 Aug; 37(32):11289-300. PubMed ID: 9698376 [TBL] [Abstract][Full Text] [Related]
11. Autophosphorylation of the Fes tyrosine kinase. Evidence for an intermolecular mechanism involving two kinase domain tyrosine residues. Rogers JA; Read RD; Li J; Peters KL; Smithgall TE J Biol Chem; 1996 Jul; 271(29):17519-25. PubMed ID: 8663427 [TBL] [Abstract][Full Text] [Related]
12. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. Yasukawa H; Misawa H; Sakamoto H; Masuhara M; Sasaki A; Wakioka T; Ohtsuka S; Imaizumi T; Matsuda T; Ihle JN; Yoshimura A EMBO J; 1999 Mar; 18(5):1309-20. PubMed ID: 10064597 [TBL] [Abstract][Full Text] [Related]
13. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor. Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227 [TBL] [Abstract][Full Text] [Related]
14. Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta. Kurzer JH; Argetsinger LS; Zhou YJ; Kouadio JL; O'Shea JJ; Carter-Su C Mol Cell Biol; 2004 May; 24(10):4557-70. PubMed ID: 15121872 [TBL] [Abstract][Full Text] [Related]
15. Receptor association and tyrosine phosphorylation of S6 kinases. Rebholz H; Panasyuk G; Fenton T; Nemazanyy I; Valovka T; Flajolet M; Ronnstrand L; Stephens L; West A; Gout IT FEBS J; 2006 May; 273(9):2023-36. PubMed ID: 16640565 [TBL] [Abstract][Full Text] [Related]
16. Tyrosines 868, 966, and 972 in the kinase domain of JAK2 are autophosphorylated and required for maximal JAK2 kinase activity. Argetsinger LS; Stuckey JA; Robertson SA; Koleva RI; Cline JM; Marto JA; Myers MG; Carter-Su C Mol Endocrinol; 2010 May; 24(5):1062-76. PubMed ID: 20304997 [TBL] [Abstract][Full Text] [Related]
17. Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor. Roskoski R Biochem Biophys Res Commun; 2005 Nov; 337(1):1-13. PubMed ID: 16129412 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of Janus kinase 3-catalyzed phosphorylation of a Janus kinase 1 activation loop peptide. Wang R; Griffin PR; Small EC; Thompson JE Arch Biochem Biophys; 2003 Feb; 410(1):7-15. PubMed ID: 12559972 [TBL] [Abstract][Full Text] [Related]
19. Expression, purification, and characterization of TYK-2 kinase domain, a member of the Janus kinase family. Korniski B; Wittwer AJ; Emmons TL; Hall T; Brown S; Wrightstone AD; Hirsch JL; Gormley JA; Weinberg RA; Leone JW; Day JE; Chrencik JE; Sommers CD; Fischer HD; Tomasselli AG Biochem Biophys Res Commun; 2010 May; 396(2):543-8. PubMed ID: 20435017 [TBL] [Abstract][Full Text] [Related]
20. Analysis of Janus tyrosine kinase phosphorylation and activation. Ross JA; Rodriguez G; Kirken RA Methods Mol Biol; 2013; 967():3-20. PubMed ID: 23296718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]